Heparin Anticoagulation to improve Outcomes in septic shock (HALO)

Principal Investigator(s):

Ryan Zarychanski, Dean Ferguson, and Anand Kumar

HALO is an international collaborative trial to evaluate whether IV unfractionated heparin reduces mortality in patients with septic shock. If unfractionated is shown to improve survival in patients with vasodilatory shock, this would forward a new standard of care for septic patients around the world.

For the latest details about HALO, visit The HALO Website.

View studies on clinicaltrials.gov:

HALO RCT

HALO Pilot

Coordinators:

Nicole Marten, Wendy Janz, Ellen McDonald, Suzy Lavoie, Irene Watpool, Tracy McArdle, Orla Smith

Participating Centres:

HALO is collaborating with over 40 sites in countries around the world, including Canada, Brazil, Greece, India, Pakistan, the Philippines and the United States.

Co-investigators:

HALO Steering Committee:

Ryan Zarychanski
Dean Fergusson
Anand Kumar
Deborah Cook
John Marshall
Alexis Turgeon
Lauralyn McIntyre
Tim Ramsay
Nicole Marten
Gloria Vázquez Grande
Mac Horsburgh
Fernando Zampieri